Business Context and Reporting Period
This Form 8-K Current Report was filed by Intelligent Bio Solutions Inc. (formerly GBS Inc.) on October 26, 2022. The filing reports significant corporate governance changes, including a change in corporate name and the appointment of new executive leadership.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on corporate structural and personnel changes.
Material Changes
- Corporate Name Change: The company officially changed its name from "GBS Inc." to "Intelligent Bio Solutions Inc." effective October 26, 2022, via a Certificate of Amendment filed with the Delaware Secretary of State.
- Stock Ticker Symbol: Commencing October 27, 2022, the company's common stock will trade on the NASDAQ Capital Market under the new symbol "INBS," replacing the former symbol "GBS."
- Executive Leadership: Harry Simeonidis was elected President and Chief Executive Officer, effective October 26, 2022. He succeeds Dr. Steven Boyages, who steps down as Interim CEO but remains Chairman of the Board.
Guidance, Outlook, and Management Commentary
The filing includes a press release (Exhibit 99.1) announcing the leadership transition and name change. Mr. Simeonidis brings over 26 years of experience in senior management roles within healthcare, pharmaceutical, and life sciences businesses, particularly in the Asia Pacific region. The filing notes that the name change does not affect stockholder rights and that existing stock certificates remain valid.
Investor Verification Checklist
- Verify the new trading symbol "INBS" on the NASDAQ Capital Market starting October 27, 2022.
- Confirm the updated corporate name "Intelligent Bio Solutions Inc." in all future filings and communications.
- Review the attached Certificate of Amendment (Exhibit 3.1) and Bylaws Amendment (Exhibit 3.2) for any additional legal details regarding the name change.
- Note that this 8-K does not provide updated financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.